{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:03:23Z","timestamp":1768475003073,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The 2C drugs are hallucinogenic phenethylamines. They and their n-benzyloxymethyl analogs have become popular as \u201clegal highs,\u201d and significant toxicity has been attributed to their use. We report on a case of seizures, systemic inflammatory response, and rhabdomyolysis associated with laboratory-confirmed 4-iodo-2,5-dimethoxyphenethylamine and 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamine exposure. A 17-year-old male teenager developed seizures after taking \u201c2 strips of acid.\u201d The seizures resolved with midazolam, but he became apneic and was intubated. His head computed tomography was unremarkable. Initial creatinine level was 1.5 mg\/dL, with a creatine kinase of 112 U\/L. His urine immunoassay drug screen was negative. He was extubated within 12 hours but had elevated temperatures for 48 hours. He was treated with antibiotics, but no source of infection was identified. His creatinine level peaked at 2.46 mg\/dL. His creatine kinase peaked 72 hours later at 14579 U\/L. He was treated with intravenous fluids and did not require renal replacement therapy. He recovered fully and was discharged after 5 days. Serum and urine samples were tested using liquid chromatography time-of-flight mass spectrometry. We detected 4-iodo-2,5-dimethoxyphenethylamine and 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamine in both serum and urine. No other substances were detected. The 2C drugs and their n-benzyloxymethyl analogs are potent serotonergic agents. Their use has been associated with multiple adverse effects including seizures, rhabdomyolysis, and death. They should be considered in differential diagnosis for drug-induced seizures and as a cause for systemic inflammatory response. This case highlights the significant toxicity seen with these compounds.<\/jats:p>","DOI":"10.1097\/pec.0000000000001117","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T15:44:47Z","timestamp":1491925487000},"page":"e181-e183","source":"Crossref","is-referenced-by-count":6,"title":["Seizures, Systemic Inflammatory Response, and Rhabdomyolysis Associated With Laboratory-Confirmed 2C-I and 25-I Exposure"],"prefix":"10.1097","volume":"34","author":[{"given":"Stephen L.","family":"Thornton","sequence":"first","affiliation":[{"name":"Poison Control Center, University of Kansas Hospital; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hoehn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Kansas Medical School, Kansas City, KS; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy R.","family":"Gerona","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of California-San Francisco, San Francisco General Hospital, San Francisco, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/15563650.2013.802795","article-title":"Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series","volume":"51","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/15563650.2015.1004179","article-title":"Prevalence of use and acute toxicity associated with the use of NBOMe drugs","volume":"53","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jat\/22.5.345","article-title":"2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market","volume":"22","year":"1998","journal-title":"J Anal Toxicol"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/dta.1570","article-title":"New phenethylamines in Europe","volume":"6","year":"2014","journal-title":"Drug Test Anal"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1016\/j.bmc.2008.04.050","article-title":"High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand","volume":"16","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2967\/jnumed.109.074021","article-title":"Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET","volume":"51","year":"2010","journal-title":"J Nucl Med"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","article-title":"Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature","volume":"56","year":"2015","journal-title":"Psychosomatics"},{"key":"bib12-20231002","first-page":"702","article-title":"Case series of 25I-NBOMe exposures with laboratory confirmation","volume":"50","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.annemergmed.2013.09.015","article-title":"Risk factors for apnea in pediatric patients transported by paramedics for out-of-hospital seizure","volume":"63","year":"2014","journal-title":"Ann Emerg Med"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/PEC.0000000000000209","article-title":"Risk factors for apnea in children presenting with out-of-hospital seizure","volume":"30","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/15563650.2014.918627","article-title":"Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center","volume":"52","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2014.03.003","article-title":"Seizures associated with synthetic cathinone exposures in the pediatric population","volume":"51","year":"2014","journal-title":"Pediatr Neurol"},{"key":"bib17-20231002","first-page":"1","article-title":"An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA","volume":"10","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","article-title":"Rhabdomyolysis: an evaluation of 475 hospitalized patients","volume":"84","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/bks043","article-title":"Three fatal intoxications due to methylone","volume":"36","year":"2012","journal-title":"J Anal Toxicol"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1556-4029.12306","article-title":"Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry","volume":"59","year":"2014","journal-title":"J Forensic Sci"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13181-013-0314-y","article-title":"2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing","volume":"10","year":"2014","journal-title":"J Med Toxicol"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.forsciint.2015.02.010","article-title":"25I-NBOMe related death in Australia: a case report","volume":"249","year":"2015","journal-title":"Forensic Sci Int"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PAF.0000000000000082","article-title":"Pathological findings in 2 cases of fatal 25I-NBOMe toxicity","volume":"35","year":"2014","journal-title":"Am J Forensic Med Pathol"},{"key":"bib25-20231002","first-page":"1","article-title":"NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System","volume":"11","year":"2015","journal-title":"Clin Toxicol (Phila)"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006565-201810000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T21:09:28Z","timestamp":1696280968000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006565-201810000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001117","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}